Financial Statements · Financial Reporting

UAB "Novo Nordisk Pharma"

Official identifier 300114028Record date 31 Dec 2022
Lithuania

Financial metrics

MetricValue
Long-term assets32,825
Current assets3,073,253
Equity1,083,042
Amounts payable and other liabilities1,928,036

Linked company

Company: UAB "Novo Nordisk Pharma"

Source

Financial Statements

View published source

Back to Financial Statements